Opioid addictions and substitution therapy


This collection of modules will provide you with useful information and training on how to best manage and treat opioid addictions. It will focus on OAT by providing an overview on buprenorphine, methadone and naloxone, the three most common medications used in the treatment of opioid addiction. It will provide pharmacists with the knowledge they need to confidently guide and counsel opioid users in pharmacy.

Course outline:
• Application of methadone guidelines to seemingly complex clinical situations – Part 1
• Basics of buprenorphine
• Chronic pain management part 1 – opioid pharmacotherapy
• Chronic pain management part 2 – nonopioid pharmacotherapy
• Dealing with difficult situations using communication techniques
• Delisting of high opioids: clinical impact and considerations
• Frequently asked questions about opioid agonist maintenance treatment – part 1
• Frequently asked questions about opioid agonist maintenance treatment – part 2
• Harm-reduction in Canada
• How to handle missed doses in Methadone Maintenance Treatment in community pharmacy
• Introduction to methadone dispensing requirements in Ontario
• Methadone and buprenorphine in patients with HIV
• Methadone and buprenorphine in pregnancy and during lactation
• Methadone maintenance: focus on drug interactions and patient safety
• Methadone maintenance therapy in Indigenous communities
• Methadone treatment patients with comorbid health problems
• Motivational interviewing
• Operationalizing Ontario’s Patch-for-Patch Fentanyl return program
• Opioid substation therapy: adolescents and young adults
• Opioid use disorder – Aberrant drug behaviours, poly substance use and psychiatric co-morbidities
• Pain management for patients receiving maintenance therapy for opioid addiction
• Pharmacology of opioid agonist treatment
• Policies guiding methadone dispensing in Ontario
• Providing inclusive care for LGBTQ+ patients
• Preventing methadone dispensing errors and handling difficult dispensing questions
• Safety and security of opioids and controlled substances dispensing
• Take-home naloxone program in community pharmacies
• Three faces of success: case studies for opioid agonist treatment
• We are people first